DA
Danielle Antalffy UBS Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
38
Avg Return
Past Year
Past Year
7.1%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
40%
Neutral
53.3%
Negative
6.7%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Technology
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Instruments & Supplies
Technology
Communication Equipment
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $95 |
13%
upside
| 2 | – |
–
| 12 Jan ‘26 6 days ago |
|
|
|
Buy
Maintained
| $12 |
85%
upside
| 1 | +82% |
0
%
| 23 Dec ‘25 26 days ago |
|
|
|
Neutral
Maintained
| $91 |
1%
downside
| 1 | -39% |
0
%
| 23 Dec ‘25 26 days ago |
|
|
|
Buy
Maintained
| $145 |
21%
upside
| 1 | +14% |
0
%
| 23 Dec ‘25 26 days ago |
|
|
|
Buy
Initiated
| $62 |
104%
upside
| 1 | -16% |
0
%
| 12 Dec ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $102 |
5%
upside
| 1 | – |
–
| 19 Nov ‘25 2 months ago |
|
|
|
Buy
Upgraded
| $400 |
39%
upside
| 1 | -14% |
0
%
| 19 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $5.85 |
122%
upside
| 1 | – |
–
| 7 Nov ‘25 2 months ago |
|
|
|
Sell
Maintained
| $88 |
1%
upside
| 1 | +5.7% |
0
%
| 6 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $16 |
15%
upside
| 1 | – |
–
| 6 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $95 |
37%
upside
| 1 | -7.6% |
0
%
| 3 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $21 |
4%
upside
| 1 | – |
–
| 31 Oct ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $600 |
12%
upside
| 1 | – |
–
| 23 Oct ‘25 2 months ago |
|
|
|
Buy
Maintained
| $140 |
59%
upside
| 1 | -5.4% |
0
%
| 23 Oct ‘25 2 months ago |
|